Reporter Feb 7 2020

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

Five things to know about China’s coronavirus outbreak

Vanderbilt infectious diseases specialist Thomas Talbot, MD, MPH, answers questions about the current novel coronavirus outbreak in China.

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

1 2